SCPH - scPharmaceuticals Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5128.95M
Enterprise Value 366.49M
Trailing P/E N/A
Forward P/E 1-3.99
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)N/A
Price/Book (mrq)2.03
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6-2.58

Trading Information

Stock Price History

Beta (3Y Monthly) N/A
52-Week Change 341.88%
S&P500 52-Week Change 33.55%
52 Week High 37.85
52 Week Low 32.44
50-Day Moving Average 36.15
200-Day Moving Average 34.10

Share Statistics

Avg Vol (3 month) 372.47k
Avg Vol (10 day) 379.23k
Shares Outstanding 518.58M
Float 11.81M
% Held by Insiders 117.32%
% Held by Institutions 177.16%
Shares Short (Aug 15, 2019) 489.93k
Short Ratio (Aug 15, 2019) 41.12
Short % of Float (Aug 15, 2019) 42.71%
Short % of Shares Outstanding (Aug 15, 2019) 40.48%
Shares Short (prior month Jul 15, 2019) 4145.15k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Jun 30, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-17.15%
Return on Equity (ttm)-35.29%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -25.82M
Net Income Avi to Common (ttm)-26.84M
Diluted EPS (ttm)-1.45
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)79.47M
Total Cash Per Share (mrq)4.28
Total Debt (mrq)11.24M
Total Debt/Equity (mrq)17.72
Current Ratio (mrq)6.04
Book Value Per Share (mrq)3.42

Cash Flow Statement

Operating Cash Flow (ttm)-21.3M
Levered Free Cash Flow (ttm)-11.49M